ICER Releases Draft Evidence Report for Several Multiple Myeloma Therapies: Will These Drugs Prevent Relapse?
ICER has released a report on three therapies for multiple myeloma: belantamab mafodotin blmf from Blenrep™ and GlaxoSmithKline, idecabtagene vicleucel [...]
COVID-19 News: Eli Lilly Drug Receives FDA Emergency Authorization; Drug Pricing Language in COVID-19 Bill
Two recent developments related to COVID-19 are a new drug approval and a relief bill containing a drug pricing proposal. [...]
Value Communications in 2021: Where can we improve?
HealthEconomics.Com is seeking at least 300 global respondents our 2021 Value Communications survey. Developing, assessing and communicating the value of [...]
A $10 Drug Price Increase Is Correlated with Higher Mortality Rate of 33%
A new study reveals that even a small increase in prescription drug prices—of only $10—can lead to higher mortality rates. [...]
CBO Paper Details Future Impact of ICER
The Congressional Budget Office (CBO) put out a draft of a paper where it notes calculations regarding Medicare drug prices. [...]
Transforming the COVID-19 Pandemic Into a Business
Thanks to widespread efforts to develop tools against COVID-19, several effective vaccines now exist. Still, data remain unclear regarding the [...]
How Can Biden Lower Drug Costs Without Impacting Innovation?
A recent article explores why drug prices are so high in the United States and delves into solutions that would [...]
Designing Clinical Trials During COVID-19 ERA
The ongoing pandemic has led to chaos in many industries, including in clinical trial design. The use of RWE (real [...]
How Should COVID-19 Vaccines Be Priced?
The US government has entered into contracts with several pharmaceutical companies to deliver COVID-19 vaccines. Although it is currently not [...]
[Whitepaper] Understanding and Using SDOH Data
SDOH (social determinants of health) data can be incredibly valuable. While these data can be immensely useful in reducing medical [...]
The Battle for FDA Commissioner
Advocacy groups are concerned that Acting Commissioner Janet Woodcock will become FDA Commissioner under the Biden administration, stating that she [...]
Pros and Cons of Newsom’s Vaccine Distributer Pick
California Governor Newsom picked Blue Shield of California to distribute COVID-19 vaccines in an emergency authorization process. The role of [...]
Matthew McHugh Appointed Director for Health Outcomes and Policy Research
Matthew McHugh is taking on a new role as Director for Health Outcomes and Policy Research (CHOPR) at the University [...]
Remdesivir Effective and Profitable for Gilead – And Controversial
Antiviral remdesivir had been developed before the onset of the global COVID-19 pandemic, but was rather unsuccessful as a treatment [...]
Cytel Whitepaper Notes Changes in Clinical Trial Design
Advances in computation tools have forever changed clinical trial design and analysis. According to Nobel Prize winning behavioral economists Daniel [...]
Why Are US Drugs 344% More Expensive?
A recent study from the RAND Corporation comparing generic and brand-name drug prices in the US to those in other [...]
New Scientist.com President Committed to Booming Future
Daniel Kagan is now President of Scientist.com. He was previously Vice President of Research and Chief Operating Officer, roles in [...]
Tenacious Sheila McLean Joins Patients for Affordable Drugs
Sheila Mclean began her position as Executive Director of Patients for Affordable Drugs in January 2021. In her new role, [...]
A Conversation with Perry Cohen on COVID-19 and PBMs
A recent episode of Tuning In to the C-Suite's Meet the Board features Perry Cohen. As CEO of The Pharmacy Group, [...]
PhRMA Details Concerns Over Recent HHS Ruling
The Department of Health and Human Services (HHS) released a mid-January ruling relating to insurance enrollment, changes to the Premium [...]
Science Invites Insight on 20th Anniversary of Human Genome Sequencing Project
Leading journal Science invited researchers to share insight into data integrity, polygenic disease risk, ethics related to genomics, the downfalls [...]
ISPOR Short Course Begins February 10th – Network Meta-Analysis in Relative Effectiveness Research
Sarah Goring and Jeroen Jansen will present a short course on February 10th and 11th for two hours per day. [...]
URAC Partners with Acentrus Specialty to Improve Patient Care
Healthcare accreditation organization URAC and pharmacy network Acentrus Specialty have partnered to improve patient outcomes and access to care. According [...]
Using RWD to Target Care Disparities in Cancer
Despite attempts to reduce or eliminate disparities in healthcare, these gaps continue to exist. When it comes to cancer, socioeconomic [...]
Governor Baker Estimates $70 Million in Overcharging Penalties
A 2022 budget proposal released by Governor Charlie Baker estimates that $70 million will be collected from pharmaceutical companies for [...]